European Archives - Page 253 of 1659 - European Medical Journal

Study Proves Favourable Safety of Apixaban Over Rivaroxaban

Study Proves Favourable Safety of Apixaban Over Rivaroxaban

Castellucci and colleagues identified that a primary-outcome event had occurred in 44 (3.3%) of the 1,345 patients taking apixaban, compared to 96 (7.1%) of the 1,355 in the rivaroxaban group.

Gut Microbiota Disruption Identified in FPIES Children

Gut Microbiota Disruption Identified in FPIES Children

Notably, children with FPIES showed reduced abundance of Bifidobacterium, a genus widely considered beneficial for gut and immune health.

Racial Discrimination Tied to Postpartum Depression and LBW

Racial Discrimination Tied to Postpartum Depression and LBW

Pregnant women subjected to interpersonal racial discrimination are substantially more likely to experience postpartum depression and delivery a baby with very low birth weight.

Gut Metabolite Enhances Fibrin Clot Formation - EMJ

Gut Metabolite Enhances Fibrin Clot Formation

By mapping the interaction between TMAO and fibrinogen, the researchers were able to identify specific binding sites and structural changes that increase clot stability.

Diacerein Fails to Improve Pain in Knee Osteoarthritis

Trial finds diacerein does not improve knee pain in osteoarthritis patients with inflammation, questioning its clinical use.

Woman in lab looking at microscope

FDA backs shift to alternatives to animal testing

The FDA has released draft guidance aimed at helping drug developers shift away from traditional animal testing.

Overview of Seladelpar▼: Emerging Selective PPAR Delta Agonist for PBC Management

When was the last time you revisited how you manage primary biliary cholangitis (PBC)? Our understanding of PBC continues to evolve, from…

Rosacea and Depression Risk: New Cohort Evidence - EMJ

Rosacea Linked to Higher Risk of Depression

Patients with rosacea may face a higher risk of depression, according to a large Korean cohort study highlighting the need for integrated care.

Faecal Microbiota Transplantation Improves Outcomes in Depression - EMJ

Faecal Microbiota Transplantation Improves Outcomes in Depression

After 2 weeks, patients in the adjunctive FMT group demonstrated significantly greater reductions in HAMD-24 scores compared with controls (p=0.048), alongside a higher overall reduction rate (p=0.016).

Four in Ten Cancer Cases Could be Prevented Globally - EMJ

Four in Ten Cancer Cases Could be Prevented Globally

Up to four in 10 cancers worldwide could be prevented, a new analysis from WHO and its International Agency for Research on Cancer has revealed.